ArticleScientific reports2024

An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy.

Muhammad Naveed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.